Predictors of carotid atherosclerosis in systemic lupus erythematosus.

scientific article

Predictors of carotid atherosclerosis in systemic lupus erythematosus. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID17014002

P50authorMichelle A. PetriQ67485110
P2093author name stringMichelle Petri
Laurence S Magder
Kathleen Maksimowicz-McKinnon
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectsystemic lupus erythematosusQ1485
atherosclerosisQ12252367
P304page(s)2458-2463
P577publication date2006-10-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titlePredictors of carotid atherosclerosis in systemic lupus erythematosus
P478volume33

Reverse relations

cites work (P2860)
Q36493881Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study.
Q37160132Association between depression and coronary artery calcification in women with systemic lupus erythematosus
Q36784328Association between depression and vascular disease in systemic lupus erythematosus
Q37690605Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events
Q34081242Cardiovascular involvement in autoimmune diseases
Q36228965Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus
Q37173453Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus
Q33570432Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Q36697443Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years
Q33389669Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus
Q50052184Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.
Q35639129Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus
Q59797299Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors
Q52316454Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.
Q45092952The early cardiovascular changes in pediatric patients with systemic lupus erythematosus
Q33584053The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus
Q36821493The role of preventive cardiology in systemic lupus erythematosus
Q57115206Ultrasound Assessment of Changes in Nails in Psoriasis and Psoriatic Arthritis
Q27005906Unmet medical needs in systemic lupus erythematosus
Q33818710Use of atorvastatin in systemic lupus erythematosus in children and adolescents